CODX vs VTR
Co-Diagnostics, Inc. Common Stock (CODX) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
CODX currently screens at market cap $31.4M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the CODX and VTR stock pages for the full models.
Not investment advice.